James M Swanson
Overview
Explore the profile of James M Swanson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
9018
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sibley M, Kennedy T, Swanson J, Eugene Arnold L, Jensen P, Hechtman L, et al.
J Clin Psychiatry
. 2024 Oct;
85(4.
PMID: 39431909
Recent studies report a fluctuating course of attention-deficit/ hyperactivity disorder (ADHD) across development characterized by intermittent periods of remission and recurrence. In the Multimodal Treatment of ADHD (MTA) study, we...
2.
Vertessen K, Oosterlaan J, Bet P, Bottelier M, Stoffelsen R, Swanson J, et al.
Eur Child Adolesc Psychiatry
. 2024 Aug;
34(3):1161-1170.
PMID: 39126498
Non-specific effects of methylphenidate treatment, including expectancy and regression to the mean effects, contribute to the overall effect of methylphenidate on attention-deficit/hyperactivity disorder (ADHD) symptoms. Knowledge on the extent to...
3.
Vajsz K, Paulina L, Trejo S, Andaverde-Vega A, Swanson J, Miklosi M
Front Psychiatry
. 2024 Jul;
15:1330716.
PMID: 39026526
The Strengths and Weaknesses of ADHD Symptoms and Normal Behaviour Scale (SWAN) measures the full spectrum of attention and activity symptoms, not just the negative end of the distribution. Previous...
4.
Baum L, Lee C, Ye R, Zhong Y, Hung S, Tang C, et al.
Ann Hum Genet
. 2024 Apr;
88(5):382-391.
PMID: 38624263
To investigate the association of attention-deficit/hyperactivity disorder (ADHD) with the 48-base pair (bp) variable number of tandem repeats (VNTR) in exon 3 of the dopamine receptor D4 (DRD4) gene, we...
5.
Vertessen K, Luman M, Bet P, Bergwerff C, Bottelier M, Stoffelsen R, et al.
Paediatr Drugs
. 2024 Jan;
26(3):319-330.
PMID: 38280943
Background And Objectives: Concerns exist regarding the rising use of methylphenidate. A double-blind, placebo-controlled methylphenidate titration (PCT) for children with attention-deficit/hyperactivity disorder (ADHD) has shown potential to improve titration (i.e.,...
6.
Molina B, Kennedy T, Howard A, Swanson J, Eugene Arnold L, Mitchell J, et al.
JAMA Psychiatry
. 2023 Jul;
80(9):933-941.
PMID: 37405756
Importance: Possible associations between stimulant treatment of attention-deficit/hyperactivity disorder (ADHD) and subsequent substance use remain debated and clinically relevant. Objective: To assess the association of stimulant treatment of ADHD with...
7.
Vertessen K, Luman M, Swanson J, Bottelier M, Stoffelsen R, Bet P, et al.
Eur Child Adolesc Psychiatry
. 2023 Mar;
33(2):495-504.
PMID: 36862163
Methylphenidate (MPH) is highly efficacious in reducing symptoms of attention-deficit/hyperactivity disorder (ADHD) in children. Generally increased doses are found to result in better symptom control; however, it remains unclear whether...
8.
Trejo S, Andaverde-Vega A, Villalobos-Gallegos L, Swanson J, Salum G
Psychol Assess
. 2022 Dec;
35(3):269-279.
PMID: 36455026
We investigate the factor structure, concurrent validity, internal consistency, measurement invariance (sex and parents' geographical/cultural background), and practical scoring practices of the Strengths and Weaknesses of Attention-deficit/Hyperactivity Disorder (ADHD)-Symptoms and...
9.
Altszuler A, Merrill B, Raiker J, Macphee F, Ramos M, Gnagy E, et al.
J Consult Clin Psychol
. 2022 May;
90(5):367-380.
PMID: 35604744
Objective: Evaluate whether stimulant medication improves acquisition of academic material in children with attention deficit hyperactivity disorder (ADHD) receiving small-group, content-area instruction in a classroom setting. Method: Participants were 173...
10.
Cotton J, Swanson J, Sonuga-Barke E, Kraemer H
J Psychiatr Res
. 2022 Apr;
150:279-281.
PMID: 35427826
No abstract available.